Information for you
On this page, you will find information on the Agency’s activities that are most relevant to healthcare professionals, including news, and events.
You can contribute to the Agency’s work by responding to public consultations.
Learn more about how Healthcare Professionals are actively involved in the work of the Agency.
Annual report on EMA patient and healthcare professional interactions
EMA has published its 2015 annual report on its interactions with patients, consumers, healthcare professionals and their organisations.The report demonstrates the Agency’s continued commitment to incorporating these stakeholders' views into the regulatory aspect of medicines development.
Involving general practitioners in regulatory decisions
A workshop with representatives of general practitioners and family doctors explored new ways to engage with providers of primary care in EU Member States and further involve them in EMA activities. EMA has published a workshop report and presentations on the workshop page.
Preparing framework of collaboration with academia
During its June meeting, the Healthcare Professionals' Working Party held a workshop to consult with representatives of academia on the pillars of a future framework of collaboration, which aims to strenghten EMA interaction with academia. EMA has published the presentations on the workshop page and will publish a full workshop report in mid-2016.
EMA has updated its online content for healthcare professionals, adding information on online resources, including relevant workshops and links and a series of short videos called EMA Basics. These cover the role of EMA, the centralised procedure and how EMA works with healthcare professionals. More videos will follow in 2016.
News for healthcare professionals
New working group will share information and best practices ... Read more
Gonzalo Calvo appointed for a second term ... Read more
Manufacturing processes for these products successfully inactivate or remove virus ... Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2016 (corrected)
Ten* medicines recommended for approval, including three medicines for cancer. ... Read more
- See all News for healthcare professionals
Events of interest
This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years. ... Read more
The European Medicines Agency is organising this workshop in collaboration with the European Commission to gather the views and proposals from stakeholders on the adaptive pathways approach, in light of the practical experience gained during the pilot project EMA ran between March 2014 and August 2016, and to plan the next steps in the exploration of this concept. Adaptive pathways is a scientific concept of medicines development and data generation intended for medicines that address patients’ unmet medical needs. ... Read more
12/09/2016 - 13/09/2016
This workshop is co-sponsored by the EMA and the Critical Path Institute. It focuses on reviewing the progress and exploring new initiatives for the International Neonatal Consortium (INC), which is dedicated to accelerating the development of safe and effective therapies for neonates. One cross-cutting topic is how to enhance a research culture. Other overarching topics are precision medicine for neonates and long-term outcome measures. Therapeutic areas that will be examined include Neonatal Abstinence Syndrome (NAS) and Necrotizing Enterocolitis (NEC). ... Read more
This information day will review signal detection and management activities essential to the overall risk management process of a medicinal product. The event will explain the impact of the implementation of the 2010 pharmacovigilance legislation, with a strong focus on signal detection and management within the European Union, emphasising the requirements to be implemented in 2017. ... Read more
15/11/2016 - 16/11/2016
Committee for Advanced Therapies (CAT) workshop: scientific and regulatory challenges of genetically modified cell-based cancer immunotherapy products
The CAT is organising a two day workshop to discuss the scientific developments and regulatory requirements for products manufacture and testing, non-clinical studies and clinical development of genetically modified cell-based cancer immunotherapy products. These novel cancer immunotherapy treatments based on genetically modified T-cells are being developed and tested in clinical trials in a variety of cancers, but there are still scientific and regulatory changes to overcome to bring these innovative products to the market. The workshop is available for participants from regulatory authorities, academia, hospitals, industry, journalists and interested members of the public. ... Read more
- See all Events of interest